JP2018512874A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018512874A5 JP2018512874A5 JP2017555218A JP2017555218A JP2018512874A5 JP 2018512874 A5 JP2018512874 A5 JP 2018512874A5 JP 2017555218 A JP2017555218 A JP 2017555218A JP 2017555218 A JP2017555218 A JP 2017555218A JP 2018512874 A5 JP2018512874 A5 JP 2018512874A5
- Authority
- JP
- Japan
- Prior art keywords
- expression vector
- pharmaceutical composition
- mammal
- kdm4d
- hyperplasia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021045410A JP7325466B2 (ja) | 2015-04-20 | 2021-03-19 | 再生医療のためのベクターおよび方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562150159P | 2015-04-20 | 2015-04-20 | |
| US62/150,159 | 2015-04-20 | ||
| PCT/US2016/028459 WO2016172224A1 (en) | 2015-04-20 | 2016-04-20 | Vectors and methods for regenerative therapy |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021045410A Division JP7325466B2 (ja) | 2015-04-20 | 2021-03-19 | 再生医療のためのベクターおよび方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018512874A JP2018512874A (ja) | 2018-05-24 |
| JP2018512874A5 true JP2018512874A5 (enExample) | 2019-05-23 |
| JP6910305B2 JP6910305B2 (ja) | 2021-07-28 |
Family
ID=57143414
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017555218A Active JP6910305B2 (ja) | 2015-04-20 | 2016-04-20 | 再生医療のためのベクターおよび方法 |
| JP2021045410A Active JP7325466B2 (ja) | 2015-04-20 | 2021-03-19 | 再生医療のためのベクターおよび方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021045410A Active JP7325466B2 (ja) | 2015-04-20 | 2021-03-19 | 再生医療のためのベクターおよび方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US11331377B2 (enExample) |
| EP (2) | EP3936188B1 (enExample) |
| JP (2) | JP6910305B2 (enExample) |
| AU (2) | AU2016252619B2 (enExample) |
| CA (1) | CA2981811A1 (enExample) |
| DK (1) | DK3285871T3 (enExample) |
| ES (1) | ES2894673T3 (enExample) |
| HU (1) | HUE055902T2 (enExample) |
| PL (1) | PL3285871T3 (enExample) |
| PT (1) | PT3285871T (enExample) |
| WO (1) | WO2016172224A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109504710B (zh) * | 2018-12-04 | 2021-03-26 | 首都医科大学附属北京口腔医院 | Kdm4d的用途 |
| WO2023056456A1 (en) * | 2021-10-01 | 2023-04-06 | University Of Washington | Vectors and methods for improving cardiac regeneration |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090275099A1 (en) | 2004-04-27 | 2009-11-05 | Regents Of The University Of Michigan | Methods and compositions for treating diseases and conditions associated with mitochondrial function |
| WO2009073618A2 (en) | 2007-11-30 | 2009-06-11 | New York Medical College | Compositions comprising hdac inhibitors and methods of their use in restoring stem cell function and preventing heart failure |
| US9260755B2 (en) * | 2012-04-11 | 2016-02-16 | University Of Massachusetts | Compositions and methods for characterizing and treating muscular dystrophy |
| WO2014014518A1 (en) * | 2012-07-18 | 2014-01-23 | Dana-Farber Cancer Institute, Inc. | Methods for treating, preventing and predicting risk of developing breast cancer |
| EP2925307B1 (en) * | 2012-11-30 | 2020-10-28 | McCord, Darlene E. | Hydroxytyrosol and oleuropein compositions for induction of dna damage, cell death and lsd1 inhibition |
| WO2015048577A2 (en) * | 2013-09-27 | 2015-04-02 | Editas Medicine, Inc. | Crispr-related methods and compositions |
-
2016
- 2016-04-20 DK DK16783775.6T patent/DK3285871T3/da active
- 2016-04-20 AU AU2016252619A patent/AU2016252619B2/en not_active Ceased
- 2016-04-20 ES ES16783775T patent/ES2894673T3/es active Active
- 2016-04-20 WO PCT/US2016/028459 patent/WO2016172224A1/en not_active Ceased
- 2016-04-20 PL PL16783775T patent/PL3285871T3/pl unknown
- 2016-04-20 EP EP21186914.4A patent/EP3936188B1/en active Active
- 2016-04-20 CA CA2981811A patent/CA2981811A1/en active Pending
- 2016-04-20 PT PT167837756T patent/PT3285871T/pt unknown
- 2016-04-20 JP JP2017555218A patent/JP6910305B2/ja active Active
- 2016-04-20 US US15/566,987 patent/US11331377B2/en active Active
- 2016-04-20 HU HUE16783775A patent/HUE055902T2/hu unknown
- 2016-04-20 EP EP16783775.6A patent/EP3285871B1/en active Active
-
2021
- 2021-03-19 JP JP2021045410A patent/JP7325466B2/ja active Active
- 2021-09-20 AU AU2021232850A patent/AU2021232850A1/en not_active Abandoned
-
2022
- 2022-04-18 US US17/659,598 patent/US20220249623A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Karpov et al. | Can the outcomes of mesenchymal stem cell‐based therapy for myocardial infarction be improved? Providing weapons and armour to cells | |
| JP7693290B2 (ja) | Ｌａｒファミリーホスファターゼの活性を阻害する組成物及び方法 | |
| Sémont et al. | Mesenchymal stem cells increase self-renewal of small intestinal epithelium and accelerate structural recovery after radiation injury | |
| Penna et al. | Pharmacologically active microcarriers influence VEGF‐A effects on mesenchymal stem cell survival | |
| Balseanu et al. | Multimodal approaches for regenerative stroke therapies: combination of granulocyte colony-stimulating factor with bone marrow mesenchymal stem cells is not superior to G-CSF alone | |
| Wu et al. | The roles of mesenchymal stem cells in tissue repair and disease modification | |
| Selsby et al. | Long-term wheel running compromises diaphragm function but improves cardiac and plantarflexor function in the mdx mouse | |
| Huang et al. | Time‐restricted release of multiple neurotrophic factors promotes axonal regeneration and functional recovery after peripheral nerve injury | |
| JP2016521708A5 (enExample) | ||
| JP2014227368A (ja) | 糖尿病および高血糖状態の処置のためのグルカゴンアナログ | |
| JP2014506787A5 (enExample) | ||
| JP2017039729A5 (enExample) | ||
| Costa et al. | Neonatal injury models: integral tools to decipher the molecular basis of cardiac regeneration | |
| Dougherty et al. | Taltirelin alleviates fatigue-like behavior in mouse models of cancer-related fatigue | |
| JP2018512874A5 (enExample) | ||
| RU2017126212A (ru) | Композиция | |
| Daneshi et al. | Cell-free treatments: a new generation of targeted therapies for treatment of ischemic heart diseases | |
| RS64553B1 (sr) | Vektori za lečenje fridrajhove ataksije | |
| Wu et al. | Current perspectives on imaging cardiac stem cell therapy | |
| JP7450244B2 (ja) | 虚血組織を治療するための方法 | |
| Pesce et al. | Endothelial and cardiac progenitors: boosting, conditioning and (re) programming for cardiovascular repair | |
| Xu et al. | Injectable myocardium-derived hydrogels with SDF-1α releasing for cardiac repair | |
| JP2017514875A (ja) | 失禁および他の括約筋不全障害を処置する方法 | |
| ES2743426T3 (es) | Proteína para inducir el crecimiento de vasos sanguíneos y usos de esta | |
| Thierry et al. | Cell therapy for the treatment of accidental radiation overexposure |